XML 27 R17.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Financial Instruments | 9 Months Ended
--- | ---
Sep. 28, 2018
Investments, All Other Investments [Abstract] |
Financial Instruments | Note 12: Financial Instruments Foreign Currencies As a multinational business, the Company’s transactions are denominated in a variety of currencies. When appropriate, the Company uses forward foreign currency contracts to reduce its overall exposure to the effects of currency fluctuations on its results of operations and cash flows. The Company’s policy prohibits trading in currencies for which there are no underlying exposures and entering into trades for any currency to intentionally increase the underlying exposure. The Company primarily hedges existing assets and liabilities associated with transactions currently on its balance sheet, which are undesignated hedges for accounting purposes. As of September 28, 2018 and December 31, 2017, the Company had net outstanding foreign exchange contracts with notional amounts of $102.6 million and $130.5 million, respectively. Such contracts were obtained through financial institutions and were scheduled to mature within one to three months from the time of purchase. Management believes that these financial instruments should not subject the Company to increased risks from foreign exchange movements because gains and losses on these contracts should offset losses and gains on the underlying assets, liabilities and transactions to which they are related. The following summarizes the Company’s net foreign exchange positions in U.S. Dollars (in millions):
|  | As of
|  | September 28, 2018 |  | December 31, 2017
|  | Buy (Sell) |  | Notional Amount |  | Buy (Sell) |  | Notional Amount
Euro |  | $ | — |  |  | $ | — |  |  | $ | (22.9 | ) |  | $ | 22.9 |
Japanese Yen |  | — |  |  | — |  |  | (40.0 | ) |  | 40.0 |
Philippine Peso |  | 32.5 |  |  | 32.5 |  |  | 26.4 |  |  | 26.4 |
Chinese Yuan |  | 18.8 |  |  | 18.8 |  |  | 5.3 |  |  | 5.3 |
Czech Koruna |  | 10.8 |  |  | 10.8 |  |  | 7.6 |  |  | 7.6 |
Other Currencies - Buy |  | 31.6 |  |  | 31.6 |  |  | 18.0 |  |  | 18.0 |
Other Currencies - Sell |  | (8.9 | ) |  | 8.9 |  |  | (10.3 | ) |  | 10.3 |
|  | $ | 84.8 |  |  | $ | 102.6 |  |  | $ | (15.9 | ) |  | $ | 130.5 |
Amounts receivable or payable under the contracts are included in other current assets or accrued expenses in the accompanying Consolidated Balance Sheets. For the quarters ended September 28, 2018 and September 29, 2017, realized and unrealized foreign currency transactions totaled a gain of $0.8 million and a loss of $2.6 million, respectively. For the nine months ended September 28, 2018 and September 29, 2017, realized and unrealized foreign currency transactions totaled a loss of $5.8 million and a loss of $5.4 million, respectively. The realized and unrealized foreign currency transactions are included in other income and expenses in the Company's Consolidated Statements of Operations and Comprehensive Income. Cash Flow Hedges All derivatives are recognized on the balance sheet at their fair value and classified based on the instrument's maturity date. Interest rate risk The Company uses interest rate swap contracts to mitigate its exposure to interest rate fluctuations associated with the Term Loan "B" Facility. The Company does not use such swap contracts for speculative or trading purposes. These contracts effectively hedge some of the future variable rate LIBOR interest expense to a fixed rate interest expense. The derivative instruments qualified for accounting as a cash flow hedge in accordance with ASC 815, and the Company designated it as such. The Company performed effectiveness assessments and concluded that there was no ineffectiveness during the quarters ended September 28, 2018 and September 29, 2017. Foreign currency risk The purpose of the Company's foreign currency hedging activities is to protect the Company from the risk that the eventual cash flows resulting from transactions in foreign currencies will be adversely affected by changes in exchange rates. The Company enters into forward contracts that are designated as foreign currency cash flow hedges of selected forecasted payments denominated in currencies other than U.S. Dollars. For the quarters and nine months ended September 28, 2018 and September 29, 2017, the Company did not have outstanding derivatives for its foreign currency exposure designated as cash flow hedges. Convertible Note Hedges The Company entered into convertible note hedges in connection with the issuance of the 1.00% Notes and 1.625% Notes. Other At September 28, 2018, the Company had no outstanding commodity derivatives, currency swaps or options relating to either its debt instruments or investments. The Company does not hedge the value of its equity investments in its subsidiaries or affiliated companies. The Company is exposed to credit-related losses if counterparties to hedge contracts fail to perform their obligations. As of September 28, 2018, the counterparties to the Company’s hedge contracts are held at financial institutions which the Company believes to be highly rated, and no credit-related losses are anticipated.

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration